-+ 0.00%
-+ 0.00%
-+ 0.00%

AJAX THERAPEUTICS RECEIVES ORPHAN DRUG DESIGNATION FROM THE U.S. FDA FOR AJ1-11095 FOR THE TREATMENT OF MYELOFIBROSIS

Reuters·12/10/2025 13:00:31

Please log in to view news